335 related articles for article (PubMed ID: 27295628)
1. Atheroprotective laminar flow inhibits Hippo pathway effector YAP in endothelial cells.
Xu S; Koroleva M; Yin M; Jin ZG
Transl Res; 2016 Oct; 176():18-28.e2. PubMed ID: 27295628
[TBL] [Abstract][Full Text] [Related]
2. Flow-dependent YAP/TAZ activities regulate endothelial phenotypes and atherosclerosis.
Wang KC; Yeh YT; Nguyen P; Limqueco E; Lopez J; Thorossian S; Guan KL; Li YJ; Chien S
Proc Natl Acad Sci U S A; 2016 Oct; 113(41):11525-11530. PubMed ID: 27671657
[TBL] [Abstract][Full Text] [Related]
3. Laminar flow inhibits the Hippo/YAP pathway via autophagy and SIRT1-mediated deacetylation against atherosclerosis.
Yuan P; Hu Q; He X; Long Y; Song X; Wu F; He Y; Zhou X
Cell Death Dis; 2020 Feb; 11(2):141. PubMed ID: 32081881
[TBL] [Abstract][Full Text] [Related]
4. Flow-Dependent Endothelial YAP Regulation Contributes to Vessel Maintenance.
Nakajima H; Yamamoto K; Agarwala S; Terai K; Fukui H; Fukuhara S; Ando K; Miyazaki T; Yokota Y; Schmelzer E; Belting HG; Affolter M; Lecaudey V; Mochizuki N
Dev Cell; 2017 Mar; 40(6):523-536.e6. PubMed ID: 28350986
[TBL] [Abstract][Full Text] [Related]
5. c-Abl regulates YAPY357 phosphorylation to activate endothelial atherogenic responses to disturbed flow.
Li B; He J; Lv H; Liu Y; Lv X; Zhang C; Zhu Y; Ai D
J Clin Invest; 2019 Mar; 129(3):1167-1179. PubMed ID: 30629551
[TBL] [Abstract][Full Text] [Related]
6. BMP9 Crosstalk with the Hippo Pathway Regulates Endothelial Cell Matricellular and Chemokine Responses.
Young K; Tweedie E; Conley B; Ames J; FitzSimons M; Brooks P; Liaw L; Vary CP
PLoS One; 2015; 10(4):e0122892. PubMed ID: 25909848
[TBL] [Abstract][Full Text] [Related]
7. Oxidized low-density lipoprotein promotes vascular endothelial cell dysfunction by stimulating miR-496 expression and inhibiting the Hippo pathway effector YAP.
Hu J; Liu T; Zhang Z; Xu Y; Zhu F
Cell Biol Int; 2019 May; 43(5):528-538. PubMed ID: 30811087
[TBL] [Abstract][Full Text] [Related]
8. Atheroprotective effects of methotrexate via the inhibition of YAP/TAZ under disturbed flow.
Liu D; Lv H; Liu Q; Sun Y; Hou S; Zhang L; Yang M; Han B; Wang G; Wang X; Du W; Nie H; Zhang R; Huang X; Hou J; Yu B
J Transl Med; 2019 Nov; 17(1):378. PubMed ID: 31730006
[TBL] [Abstract][Full Text] [Related]
9. YAP Subcellular Localization and Hippo Pathway Transcriptome Analysis in Pediatric Hepatocellular Carcinoma.
LaQuaglia MJ; Grijalva JL; Mueller KA; Perez-Atayde AR; Kim HB; Sadri-Vakili G; Vakili K
Sci Rep; 2016 Sep; 6():30238. PubMed ID: 27605415
[TBL] [Abstract][Full Text] [Related]
10. The PDZ-binding motif of Yes-associated protein is required for its co-activation of TEAD-mediated CTGF transcription and oncogenic cell transforming activity.
Shimomura T; Miyamura N; Hata S; Miura R; Hirayama J; Nishina H
Biochem Biophys Res Commun; 2014 Jan; 443(3):917-23. PubMed ID: 24380865
[TBL] [Abstract][Full Text] [Related]
11. Integrin α2β1 inhibits MST1 kinase phosphorylation and activates Yes-associated protein oncogenic signaling in hepatocellular carcinoma.
Wong KF; Liu AM; Hong W; Xu Z; Luk JM
Oncotarget; 2016 Nov; 7(47):77683-77695. PubMed ID: 27765911
[TBL] [Abstract][Full Text] [Related]
12. Angiomotins stimulate LATS kinase autophosphorylation and act as scaffolds that promote Hippo signaling.
Mana-Capelli S; McCollum D
J Biol Chem; 2018 Nov; 293(47):18230-18241. PubMed ID: 30266805
[TBL] [Abstract][Full Text] [Related]
13. Yes-associated protein (YAP) signaling regulates lipopolysaccharide-induced tissue factor expression in human endothelial cells.
Yi L; Huang X; Guo F; Zhou Z; Dou Y; Huan J
Surgery; 2016 May; 159(5):1436-48. PubMed ID: 26791271
[TBL] [Abstract][Full Text] [Related]
14. Tumor suppressor LATS1 is a negative regulator of oncogene YAP.
Hao Y; Chun A; Cheung K; Rashidi B; Yang X
J Biol Chem; 2008 Feb; 283(9):5496-509. PubMed ID: 18158288
[TBL] [Abstract][Full Text] [Related]
15. Yes-associated protein regulates endothelial cell contact-mediated expression of angiopoietin-2.
Choi HJ; Zhang H; Park H; Choi KS; Lee HW; Agrawal V; Kim YM; Kwon YG
Nat Commun; 2015 May; 6():6943. PubMed ID: 25962877
[TBL] [Abstract][Full Text] [Related]
16. YAP and the RhoC regulator ARHGAP18, are required to mediate flow-dependent endothelial cell alignment.
Coleman PR; Lay AJ; Ting KK; Zhao Y; Li J; Jarrah S; Vadas MA; Gamble JR
Cell Commun Signal; 2020 Feb; 18(1):18. PubMed ID: 32013974
[TBL] [Abstract][Full Text] [Related]
17. Regulation of Yes-Associated Protein by Laminar Flow.
Chitragari G; Shalaby SY; Sumpio BJ; Kurita J; Sumpio BE
Ann Vasc Surg; 2018 Oct; 52():183-191. PubMed ID: 29758328
[TBL] [Abstract][Full Text] [Related]
18. YAP and TAZ Negatively Regulate Prox1 During Developmental and Pathologic Lymphangiogenesis.
Cho H; Kim J; Ahn JH; Hong YK; Mäkinen T; Lim DS; Koh GY
Circ Res; 2019 Jan; 124(2):225-242. PubMed ID: 30582452
[TBL] [Abstract][Full Text] [Related]
19. Serum deprivation inhibits the transcriptional co-activator YAP and cell growth via phosphorylation of the 130-kDa isoform of Angiomotin by the LATS1/2 protein kinases.
Adler JJ; Johnson DE; Heller BL; Bringman LR; Ranahan WP; Conwell MD; Sun Y; Hudmon A; Wells CD
Proc Natl Acad Sci U S A; 2013 Oct; 110(43):17368-73. PubMed ID: 24101513
[TBL] [Abstract][Full Text] [Related]
20. Furry protein suppresses nuclear localization of yes-associated protein (YAP) by activating NDR kinase and binding to YAP.
Irie K; Nagai T; Mizuno K
J Biol Chem; 2020 Mar; 295(10):3017-3028. PubMed ID: 31996378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
